Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes

INTRODUCTION: A high hemoglobin glycation index (HGI) and glycated hemoglobin (HbA1c) level are associated with greater inflammatory status, and dipeptidyl peptidase-4 (DPP-4) inhibitors can suppress inflammation. We aimed to evaluate the relationship between HGI and the therapeutic effect of DPP-4...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Wei, Wang, Jun-Sing, Sheu, Wayne H-H, Lin, Shih-Yi, Lee, I-Te, Song, Yuh-Min, Fu, Chia-Po, Lee, Chia-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300176/
https://www.ncbi.nlm.nih.gov/pubmed/28182722
http://dx.doi.org/10.1371/journal.pone.0171753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300176/
https://www.ncbi.nlm.nih.gov/pubmed/28182722
http://dx.doi.org/10.1371/journal.pone.0171753

Ejemplares similares